One week sunitinib treatment also resulted in increased mRNA expression levels of VEGFA, CD31 (an endothelial cell marker), Oct4 and Snail compared to the control treatment group, supporting that short term sunitinib treatment induces greater hypoxia in the tumor tissue (Figure 5d). The gene discussed is PECAM1; the disease is neoplasm.